OPRA vs. AZN
Compare and contrast key facts about Opera Limited (OPRA) and AstraZeneca PLC (AZN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: OPRA or AZN.
Correlation
The correlation between OPRA and AZN is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
OPRA vs. AZN - Performance Comparison
Loading data...
Key characteristics
OPRA:
0.80
AZN:
-0.43
OPRA:
1.41
AZN:
-0.45
OPRA:
1.16
AZN:
0.94
OPRA:
0.63
AZN:
-0.38
OPRA:
2.60
AZN:
-0.66
OPRA:
14.21%
AZN:
15.75%
OPRA:
51.92%
AZN:
23.21%
OPRA:
-72.85%
AZN:
-48.94%
OPRA:
-28.99%
AZN:
-21.35%
Fundamentals
OPRA:
$1.66B
AZN:
$207.93B
OPRA:
$0.93
AZN:
$2.48
OPRA:
19.92
AZN:
26.71
OPRA:
3.18
AZN:
3.78
OPRA:
1.78
AZN:
5.00
OPRA:
$522.43M
AZN:
$54.98B
OPRA:
$265.69M
AZN:
$44.75B
OPRA:
$110.97M
AZN:
$17.70B
Returns By Period
In the year-to-date period, OPRA achieves a -1.74% return, which is significantly lower than AZN's 5.18% return.
OPRA
-1.74%
22.76%
1.70%
40.92%
33.66%
N/A
AZN
5.18%
0.13%
5.95%
-9.92%
7.40%
10.46%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
OPRA vs. AZN — Risk-Adjusted Performance Rank
OPRA
AZN
OPRA vs. AZN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Opera Limited (OPRA) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
OPRA vs. AZN - Dividend Comparison
OPRA's dividend yield for the trailing twelve months is around 4.39%, more than AZN's 2.25% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPRA Opera Limited | 4.39% | 4.22% | 9.07% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AZN AstraZeneca PLC | 2.25% | 2.27% | 2.15% | 2.14% | 2.40% | 2.80% | 2.81% | 3.61% | 3.95% | 5.01% | 4.06% | 3.98% |
Drawdowns
OPRA vs. AZN - Drawdown Comparison
The maximum OPRA drawdown since its inception was -72.85%, which is greater than AZN's maximum drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for OPRA and AZN. For additional features, visit the drawdowns tool.
Loading data...
Volatility
OPRA vs. AZN - Volatility Comparison
Opera Limited (OPRA) has a higher volatility of 12.36% compared to AstraZeneca PLC (AZN) at 8.44%. This indicates that OPRA's price experiences larger fluctuations and is considered to be riskier than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
OPRA vs. AZN - Financials Comparison
This section allows you to compare key financial metrics between Opera Limited and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
OPRA vs. AZN - Profitability Comparison
OPRA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Opera Limited reported a gross profit of 64.35M and revenue of 143.44M. Therefore, the gross margin over that period was 44.9%.
AZN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AstraZeneca PLC reported a gross profit of 11.35B and revenue of 13.59B. Therefore, the gross margin over that period was 83.5%.
OPRA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Opera Limited reported an operating income of 21.94M and revenue of 143.44M, resulting in an operating margin of 15.3%.
AZN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AstraZeneca PLC reported an operating income of 3.67B and revenue of 13.59B, resulting in an operating margin of 27.0%.
OPRA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Opera Limited reported a net income of 18.38M and revenue of 143.44M, resulting in a net margin of 12.8%.
AZN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AstraZeneca PLC reported a net income of 2.92B and revenue of 13.59B, resulting in a net margin of 21.5%.